8-25296564-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024940.8(DOCK5):c.522C>A(p.Asp174Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,460,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024940.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOCK5 | NM_024940.8 | c.522C>A | p.Asp174Glu | missense_variant | 7/52 | ENST00000276440.12 | NP_079216.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOCK5 | ENST00000276440.12 | c.522C>A | p.Asp174Glu | missense_variant | 7/52 | 1 | NM_024940.8 | ENSP00000276440.7 | ||
DOCK5 | ENST00000481100.5 | c.522C>A | p.Asp174Glu | missense_variant | 7/11 | 1 | ENSP00000429737.1 | |||
DOCK5 | ENST00000495236.1 | n.-18C>A | upstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247678Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133822
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460014Hom.: 0 Cov.: 30 AF XY: 0.00000964 AC XY: 7AN XY: 726090
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.522C>A (p.D174E) alteration is located in exon 7 (coding exon 7) of the DOCK5 gene. This alteration results from a C to A substitution at nucleotide position 522, causing the aspartic acid (D) at amino acid position 174 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at